SELLAS Life Sciences Group Inc (SLS)
1.29
-0.04
(-3.01%)
USD |
NASDAQ |
May 06, 16:00
1.32
+0.03
(+2.33%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash from Operations (Quarterly): -4.825M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.825M |
| September 30, 2023 | -6.892M |
| June 30, 2023 | -7.566M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -5.152M |
| September 30, 2022 | -5.746M |
| June 30, 2022 | -5.761M |
| March 31, 2022 | -7.15M |
| December 31, 2021 | -4.976M |
| September 30, 2021 | -5.878M |
| June 30, 2021 | -4.898M |
| March 31, 2021 | -10.27M |
| December 31, 2020 | 3.424M |
| September 30, 2020 | -3.629M |
| June 30, 2020 | -3.381M |
| March 31, 2020 | -6.831M |
| December 31, 2019 | -4.176M |
| September 30, 2019 | -3.82M |
| June 30, 2019 | -4.656M |
| March 31, 2019 | -4.991M |
| December 31, 2018 | -4.555M |
| September 30, 2018 | -14.16M |
| June 30, 2018 | -6.299M |
| March 31, 2018 | -5.403M |
| December 31, 2017 | 15.25M |
| Date | Value |
|---|---|
| September 30, 2017 | -19.39M |
| June 30, 2017 | -3.049M |
| March 31, 2017 | -3.803M |
| December 31, 2016 | 25.06M |
| September 30, 2016 | -12.21M |
| June 30, 2016 | -11.49M |
| March 31, 2016 | -13.22M |
| December 31, 2015 | -15.28M |
| September 30, 2015 | -9.46M |
| June 30, 2015 | -11.86M |
| March 31, 2015 | -11.56M |
| December 31, 2014 | -10.73M |
| September 30, 2014 | -11.12M |
| June 30, 2014 | -12.97M |
| March 31, 2014 | -8.048M |
| December 31, 2013 | -8.492M |
| September 30, 2013 | -7.983M |
| June 30, 2013 | -7.123M |
| March 31, 2013 | -5.331M |
| December 31, 2012 | -5.178M |
| September 30, 2012 | -4.165M |
| June 30, 2012 | -6.745M |
| March 31, 2012 | -4.885M |
| December 31, 2011 | -4.169M |
| September 30, 2011 | -3.413M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.13M
Minimum
Mar 2023
3.424M
Maximum
Dec 2020
-5.490M
Average
-5.152M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Geron Corp | -62.25M |
| Immuneering Corp | -11.78M |
| Protagonist Therapeutics Inc | 16.96M |
| Akebia Therapeutics Inc | -2.308M |
| Moderna Inc | -989.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 3.386M |
| Free Cash Flow | -36.91M |
| Free Cash Flow Per Share (Quarterly) | -0.1566 |
| Free Cash Flow Yield | -103.1% |